NCT04170985View on ClinicalTrials.gov

NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology

CompletedOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

November 18, 2019

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Neurologic DeficitsNeurologic DisorderNeurologic Abnormalities
Interventions
OTHER

clinical Whole Genome Sequencing

Participants will receive cWGS as well as standard of care testing. The clinician/site PI will be blinded to the cWGS results until Day 180.

Trial Locations (1)

19104

Univ. of Pennsylvania, Philadelphia

Sponsors

Lead Sponsor

Illumina, Inc.
All Listed Sponsors
lead

Illumina, Inc.

INDUSTRY